Reduction of graphene oxide by resveratrol: A novel and simple biological method for the synthesis of an effective anticancer nanotherapeutic molecule

International Journal of Nanomedicine

Volumn 10, Issue , 2015, Pages 2951-2969

  Gurunathan, Sangiliyandi ^a   Han, Jae Woong ^a   Kim, Eun Su ^a   Park, Jung Hyun ^a   Kim, Jin Hoi ^a  

^a Konkuk University   (South Korea)

Author keywords

Membrane integrity; Raman spectroscopy; Reduced graphene oxide; ROS generation; Scanning electron microscopy; UV vis spectroscopy

Indexed keywords

ALKALINE PHOSPHATASE; CASPASE 3; GRAPHENE OXIDE; REACTIVE OXYGEN METABOLITE; RESVERATROL; ANTINEOPLASTIC AGENT; GRAPHITE; NANOMATERIAL; OXIDE; STILBENE DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; ATOMIC FORCE MICROSCOPY; CELL SURVIVAL; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG MECHANISM; DRUG SYNTHESIS; ENZYME ACTIVATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; INFRARED SPECTROSCOPY; LIGHT SCATTERING; NANOTECHNOLOGY; OVARIAN CANCER CELL LINE; OXIDATIVE STRESS; PARTICLE SIZE; RAMAN SPECTROMETRY; SCANNING ELECTRON MICROSCOPY; ULTRAVIOLET SPECTROSCOPY; UPREGULATION; X RAY DIFFRACTION; CHEMISTRY; DRUG EFFECTS; NANOMEDICINE; OXIDATION REDUCTION REACTION; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; GRAPHITE; HUMANS; NANOMEDICINE; NANOSTRUCTURES; OXIDATION-REDUCTION; OXIDES; STILBENES;

EID: 84928137624     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S79879     Document Type: Article

References (108)

1. Loh KP, Bao QL, Eda G, Chhowalla M. Graphene oxide as a chemically tunable platform for optical applications. Nat Chem. 2010;2(12):1015-1024.
2. Eda G, Fanchini G, Chhowalla M. Large-area ultrathin films of reduced graphene oxide as a transparent and flexible electronic material. Nat Nanotechnol. 2008;3(5):270-274.
3. Zhu XJ, Zhu YW, Murali S, Stollers MD, Ruoff RS. Nanostructured reduced graphene oxide/Fe2O3 composite as a high-performance anode material for lithium ion batteries. ACS Nano. 2011;5(4):3333-3338.
4. Kumar PV, Bardhan NM, Tongay S, Wu J, Belcher AM, Grossman JC. Scalable enhancement of graphene oxide properties by thermally driven phase transformation. Nat Chem. 2014;6(2):151-158.
5. Geim AK, Novoselov KS. The rise of graphene. Nat Mater. 2007;6(3):183-191.
6. Kim YK, Kim MH, Min DH. Biocompatible reduced graphene oxide prepared by using dextran as a multifunctional reducing agent. Chem Commun. 2011;47(11):3195-3197.
7. Park S, Ruoff RS. Chemical methods for the production of graphenes. Nat Nanotechnol. 2009;4(4):217-224.
8. Gurunathan S, Han J, Kim JH. Humanin: a novel functional molecule for the green synthesis of graphene. Colloids Surf B Biointerfaces. 2013;111:376-383.
9. Gurunathan S, Han J, Park JH, Kim JH. An in vitro evaluation of graphene oxide reduced by Ganoderma spp. in human breast cancer cells (MDA-MB-231). Int J Nanomedicine. 2014;9:1783-1797.
10. Li XL, Wang XR, Zhang L, Lee SW, Dai HJ. Chemically derived, ultrasmooth graphene nanoribbon semiconductors. Science. 2008;319(5867):1229-1232.
11. Lu CH, Yang HH, Zhu CL, Chen X, Chen GN. A graphene platform for sensing biomolecules. Angew Chem Int Ed Engl. 2009;48(26):4785-4787.
12. Hu W, Peng C, Luo W, et al. Graphene-based antibacterial paper. ACS Nano. 2010;4(7):4317-4323.
13. Gurunathan S, Han JW, Dayem AA, Eppakayala V, Kim JH. Oxidative stress-mediated antibacterial activity of graphene oxide and reduced graphene oxide in Pseudomonas aeruginosa. Int J Nanomedicine. 2012;7:5901-5914.
14. Akhavan O, Ghaderi E. Toxicity of graphene and graphene oxide nanowalls against bacteria. ACS Nano. 2010;4(10):5731-5736.
15. Sun X, Liu Z, Welsher K, et al. Nano-graphene oxide for cellular imaging and drug delivery. Nano Res. 2008;1(3):203-212.
16. Nayak TR, Andersen H, Makam VS, et al. Graphene for controlled and accelerated osteogenic differentiation of human mesenchymal stem cells. ACS Nano. 2011;5(6):4670-4678.
17. Stankovich S, Dikin DA, Piner RD, et al. Synthesis of graphene-based nanosheets via chemical reduction of exfoliated graphite oxide. Carbon N Y. 2007;45(7):1558-1565.
18. Cote LJ, Cruz-Silva R, Huang JX. Flash reduction and patterning of graphite oxide and its polymer composite. J Am Chem Soc. 2009;131(31):11027-11032.
19. Zhou Y, Bao QL, Tang LAL, Zhong YL, Loh KP. Hydrothermal dehydration for the "green" reduction of exfoliated graphene oxide to graphene and demonstration of tunable optical limiting properties. Chem Mater. 2009;21(13):2950-2956.
20. Dreyer DR, Ruoff RS, Bielawski CW. From conception to realization: an historial account of graphene and some perspectives for its future. Angew Chem Int Ed Engl. 2010;49(49):9336-9344.
21. Hass J, de Heer WA, Conrad EH. The growth and morphology of epitaxial multilayer graphene. J Phys Condens Matter. 2008;20(32):323202.
22. Akhavan O, Ghaderi E. Photocatalytic reduction of graphene oxide nanosheets on TiO2 thin film for photoinactivation of bacteria in solar light irradiation. J Phys Chem C. 2009;113(47):20214-20220.
23. Akhavan O, Abdolahad M, Esfandiar A, Mohatashamifar M. Photodegradation of graphene oxide sheets by TiO2 nanoparticles after a photocatalytic reduction. J Phys Chem C. 2010;114(30):12955-12959.
24. Su CY, Lu AY, Xu YP, Chen FR, Khlobystov AN, Li LJ. High-quality thin graphene films from fast electrochemical exfoliation. ACS Nano. 2011;5(3):2332-2339.
25. Yang J, Strickler JR, Gunasekaran S. Indium tin oxide-coated glass modified with reduced graphene oxide sheets and gold nanoparticles as disposable working electrodes for dopamine sensing in meat samples. Nanoscale. 2012;4(15):4594-4602.
26. Khanra P, Kuila T, Kim NH, Bae SH, Yu DS, Lee JH. Simultaneous bio-functionalization and reduction of graphene oxide by baker's yeast. Chem Eng J. 2012;183:526-533.
27. Akhavan O, Choobtashani M, Ghaderi E. Protein degradation and RNA efflux of viruses photocatalyzed by graphene-tungsten oxide composite under visible light irradiation. J Phys Chem C. 2012;116(17):9653-9659.
28. Gurunathan S, Han JW, Eppakayala V, Kim JH. Biocompatibility of microbially reduced graphene oxide in primary mouse embryonic fibroblast cells. Colloids Surf B Biointerfaces. 2013;105:58-66.
29. Stankovich S, Piner RD, Chen XQ, Wu NQ, Nguyen ST, Ruoff RS. Stable aqueous dispersions of graphitic nanoplatelets via the reduction of exfoliated graphite oxide in the presence of poly(sodium 4-styrenesulfonate). J Mater Chem. 2006;16(2):155-158.
30. Fan XB, Peng WC, Li Y, et al. Deoxygenation of exfoliated graphite oxide under alkaline conditions: a green route to graphene preparation. Adv Mater. 2008;20(23):4490-4493.
31. Tang LA, Lee WC, Shi H, et al. Highly wrinkled cross-linked graphene oxide membranes for biological and charge-storage applications. Small. 2012;8(3):423-431.
32. Min K, Han TH, Kim J, et al. A facile route to fabricate stable reduced graphene oxide dispersions in various media and their transparent conductive thin films. J Colloid Interface Sci. 2012;383:36-42.
33. Salas EC, Sun ZZ, Luttge A, Tour JM. Reduction of graphene oxide via bacterial respiration. ACS Nano. 2010;4(8):4852-4856.
34. Wang GM, Qian F, Saltikov C, Jiao YQ, Li Y. Microbial reduction of graphene oxide by Shewanella. Nano Res. 2011;4(6):563-570.
35. Akhavan O, Ghaderi E. Escherichia coli bacteria reduce graphene oxide to bactericidal graphene in a self-limiting manner. Carbon N Y. 2012;50(5):1853-1860.
36. Gurunathan S, Han JW, Eppakayala V, Kim JH. Green synthesis of graphene and its cytotoxic effects in human breast cancer cells. Int J Nanomedicine. 2013;8:1015-1027.
37. Fernandez-Merino MJ, Guardia L, Paredes JI, et al. Vitamin C Is an ideal substitute for hydrazine in the reduction of graphene oxide suspensions. J Phys Chem C. 2010;114(14):6426-6432.
38. Gao J, Liu F, Liu YL, Ma N, Wang ZQ, Zhang X. Environment-friendly method to produce graphene that employs vitamin c and amino acid. Chem Mater. 2010;22(7):2213-2218.
39. Zhu CZ, Guo SJ, Fang YX, Dong S. Reducing sugar: new functional molecules for the green synthesis of graphene nanosheets. ACS Nano. 2010;4(4):2429-2437.
40. Akhavan O, Ghaderi E, Aghayee S, Fereydooni Y, Talebi A. The use of a glucose-reduced graphene oxide suspension for photothermal cancer therapy. J Mater Chem. 2012;22(27):13773-13781.
41. Liu JB, Fu SH, Yuan B, Li YL, Deng ZX. Toward a universal "adhesive nanosheet" for the assembly of multiple nanoparticles based on a protein-induced reduction/decoration of graphene oxide. J Am Chem Soc. 2010;132(21):7279.
42. Esfandiar A, Akhavan O, Irajizad A. Melatonin as a powerful bio-antioxidant for reduction of graphene oxide. J Mater Chem. 2011;21(29):10907-10914.
43. Deepak V, Umamaheshwaran PS, Guhan K, et al. Synthesis of gold and silver nanoparticles using purified URAK. Colloids Surf B Biointerfaces. 2011;86(2):353-358.
44. Vallhov H, Qin J, Johansson SM, et al. The importance of an endotoxin-free environment during the production of nanoparticles used in medical applications. Nano Lett. 2006;6(8):1682-1686.
45. Yang K, Zhang SA, Zhang GX, Sun XM, Lee ST, Liu ZA. Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy. Nano Lett. 2010;10(9):3318-3323.
46. Markovic ZM, Harhaji-Trajkovic LM, Todorovic-Markovic BM, et al. In vitro comparison of the photothermal anticancer activity of graphene nanoparticles and carbon nanotubes. Biomaterials. 2011;32(4): 1121-1129.
47. Kam NWS, O'Connell M, Wisdom JA, Dai HJ. Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction. Proc Natl Acad Sci U S A. 2005;102(33):11600-11605.
48. Zhang W, Guo ZY, Huang DQ, Liu ZM, Guo X, Zhong HQ. Synergistic effect of chemo-photothermal therapy using PEGylated graphene oxide. Biomaterials. 2011;32(33):8555-8561.
49. Jemal A, Thomas A, Murray T, Thun M. Cancer statistics, 2002. CA Cancer J Clin. 2002;52(1):23-47.
50. Opipari AW, Tan LJ, Boitano AE, Sorenson DR, Aurora A, Liu JR. Resveratrol-induced autophagocytosis in ovarian cancer cells. Cancer Res. 2004;64(2):696-703.
51. Kalil NGN, McGuire WP. Chemotherapy for advanced epithelial ovarian carcinoma. Best Pract Res Clin Obstet Gynaecol. 2002;16(4):553.
52. Gusman J, Malonne H, Atassi G. A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol. Carcinogenesis. 2001;22(8):1111-1117.
53. Pervaiz S, Holme AL. Resveratrol: its biologic targets and functional activity. Antioxid Redox Signal. 2009;11(11):2851-2897.
54. Bhat KPL, Pezzuto JM. Cancer chemopreventive activity of resveratrol. Ann N Y Acad Sci. 2002;957:210-229.
55. Mgbonyebi OP, Russo J, Russo IH. Antiproliferative effect of synthetic resveratrol on human breast epithelial cells. Int J Oncol. 1998;12(4):865-869.
56. Ragione FD, Cucciolla V, Borriello A, et al. Resveratrol arrests the cell division cycle at S/G2 phase transition. Biochem Biophys Res Commun. 1998;250(1):53-58.
57. Hsieh TC, Juan G, Darzynkiewicz Z, Wu JM. Resveratrol increases nitric oxide synthase, induces accumulation of p53 and p21(WAF1/CIP1), and suppresses cultured bovine pulmonary artery endothelial cell proliferation by perturbing progression through S and G2. Cancer Res. 1999;59(11):2596-2601.
58. Svajger U, Jeras M. Anti-inflammatory effects of resveratrol and its potential use in therapy of Immune-mediated diseases. Int Rev Immunol. 2012;31(3):202-222.
59. Hummers WS, Offeman RE. Preparation of graphitic oxide. J Am Chem Soc. 1958;80:1339.
60. Gurunathan S, Han JW, Eppakayala V, Jeyaraj M, Kim JH. Cytotoxicity of biologically synthesized silver nanoparticles in MDA-MB-231 human breast cancer cells. Biomed Res Int. 2013:535796.
61. Gurunathan S, Han JW, Park JH, Eppakayala V, Kim JH. Ginkgo biloba: a natural reducing agent for the synthesis of cytocompatible graphene. Int J Nanomedicine. 2014;9:363-377.
62. Eda G, Lin YY, Mattevi C, et al. Blue photoluminescence from chemically derived graphene oxide. Adv Mater. 2010;22(4):505.
63. Ding SJ, Chen JS, Luan DY, Boey FYC, Madhavi S, Lou XW. Graphene-supported anatase TiO2 nanosheets for fast lithium storage. Chem Commun. 2011;47(20):5780-5782.
64. Mhamane D, Ramadan W, Fawzy M, et al. From graphite oxide to highly water dispersible functionalized graphene by single step plant extract-induced deoxygenation. Green Chem. 2011;13(8):1990-1996.
65. Zhang JL, Yang HJ, Shen GX, Cheng P, Zhang JY, Guo SW. Reduction of graphene oxide via L-ascorbic acid. Chem Commun. 2010;46(7):1112-1114.
66. Chen DZ, Li LD, Guo L. An environment-friendly preparation of reduced graphene oxide nanosheets via amino acid. Nanotechnology. 2011;22(32):325601.
67. Gurunathan S, Han JW, Kim E, Kwon DN, Park JK, Kim JH. Enhanced green fluorescent protein-mediated synthesis of biocompatible graphene. J Nanobiotechnology. 2014;12:41.
68. Lammel T, Boisseaux P, Fernandez-Cruz ML, Navas JM. Internalization and cytotoxicity of graphene oxide and carboxyl graphene nanoplatelets in the human hepatocellular carcinoma cell line Hep G2. Part Fibre Toxicol. 2013;10:27.
69. Wang Y, Zhang P, Liu CF, Zhan L, Li YF, Huang CZ. Green and easy synthesis of biocompatible graphene for use as an anticoagulant. RSC Adv. 2012;2(6):2322-2328.
70. Liu S, Zeng TH, Hofmann M, et al. Antibacterial activity of graphite, graphite oxide, graphene oxide, and reduced graphene oxide: membrane and oxidative stress. ACS Nano. 2011;5(9):6971-6980.
71. Jeong HK, Lee YP, Lahaye RJ, et al. Evidence of graphitic AB stacking order of graphite oxides. J Am Chem Soc. 2008;130(4):1362-1366.
72. Lian PC, Zhu XF, Liang SZ, Li Z, Yang WS, Wang HH. Large reversible capacity of high quality graphene sheets as an anode material for lithium-ion batteries. Electrochim Acta. 2010;55(12):3909-3914.
73. He HK, Gao C. Supraparamagnetic, conductive, and processable multifunctional graphene nanosheets coated with high-density Fe3O4 nanoparticles. ACS Appl Mater Interfaces. 2010;2(11):3201-3210.
74. Ferrari AC, Robertson J. Resonant Raman spectroscopy of disordered, amorphous, and diamondlike carbon. Phys Rev B. 2001;64(7):075414.
75. Wang GX, Yang J, Park J, et al. Facile synthesis and characterization of graphene nanosheets. J Phys Chem C. 2008;112(22):8192-8195.
76. Guo YQ, Sun XY, Liu Y, Wang W, Qiu HX, Gao JP. One pot preparation of reduced graphene oxide (RGO) or Au (Ag) nanoparticle-RGO hybrids using chitosan as a reducing and stabilizing agent and their use in methanol electrooxidation. Carbon N Y. 2012;50(7):2513-2523.
77. Gurunathan S, Han JW, Eppakayala V, Dayem AA, Kwon DN, Kim JH. Biocompatibility effects of biologically synthesized graphene in primary mouse embryonic fibroblast cells. Nanoscale Res Lett. 2013;8(1):393.
78. Hu XZ, Xu Z, Gao C. Multifunctional, supramolecular, continuous artificial nacre fibres. Sci Rep. 2012;2:767.
79. Xu Z, Gao C. Graphene chiral liquid crystals and macroscopic assembled fibres. Nat Commun. 2011;2:571.
80. Su CY, Xu YP, Zhang WJ, et al. Electrical and spectroscopic characterizations of ultra-large reduced graphene oxide monolayers. Chem Mater. 2009;21(23):5674-5680.
81. Liu Y, Luo Y, Wu J, et al. Graphene oxide can induce in vitro and in vivo mutagenesis. Sci Rep. 2013;3:3469.
82. Li Y, Liu Y, Fu Y, et al. The triggering of apoptosis in macrophages by pristine graphene through the MAPK and TGF-beta signaling pathways. Biomaterials. 2012;33(2):402-411.
83. Zhang Y, Ali SF, Dervishi E, et al. Cytotoxicity effects of graphene and single-wall carbon nanotubes in neural phaeochromocytoma-derived PC12 cells. ACS Nano. 2010;4(6):3181-3186.
84. Akhavan O, Ghaderi E, Akhavan A. Size-dependent genotoxicity of graphene nanoplatelets in human stem cells. Biomaterials. 2012;33(32):8017-8025.
85. Akhavan O, Ghaderi E, Emamy H, Akhavan F. Genotoxicity of graphene nanoribbons in human mesenchymal stem cells. Carbon N Y. 2013;54:419-431.
86. Jaworski S, Sawosz E, Grodzik M, et al. In vitro evaluation of the effects of graphene platelets on glioblastoma multiforme cells. Int J Nanomedicine. 2013;8:413-420.
87. Wang K, Ruan J, Song H, et al. Biocompatibility of graphene oxide. Nanoscale Res Lett. 2011;6(1):8.
88. Wang A, Pu K, Dong B, et al. Role of surface charge and oxidative stress in cytotoxicity and genotoxicity of graphene oxide towards human lung fibroblast cells. J Appl Toxicol. 2013;33(10):1156-1164.
89. Sayes CM, Liang F, Hudson JL, et al. Functionalization density dependence of single-walled carbon nanotubes cytotoxicity in vitro. Toxicol Lett. 2006;161(2):135-142.
90. Clutton S. The importance of oxidative stress in apoptosis. Br Med Bull. 1997;53(3):662-668.
91. Knaapen AM, Borm PJA, Albrecht C, Schins RPF. Inhaled particles and lung cancer. Part A: Mechanisms. Int J Cancer. 2004;109(6):799-809.
92. Reddy ARN, Reddy YN, Krishna DR, Himabindu V. Multi wall carbon nanotubes induce oxidative stress and cytotoxicity in human embryonic kidney (HEK293) cells. Toxicology. 2010;272(1-3):11-16.
93. Wu QL, Zhao YL, Li YP, Wang DY. Molecular signals regulating translocation and toxicity of graphene oxide in the nematode Caenorhabditis elegans. Nanoscale. 2014;6(19):11204-11212.
94. Shen JF, Hu YH, Li C, Qin C, Ye MX. Synthesis of amphiphilic graphene nanoplatelets. Small. 2009;5(1):82-85.
95. Thevenot P, Cho J, Wavhal D, Timmons RB, Tang LP. Surface chemistry influences cancer killing effect of TiO2 nanoparticles. Nanomedicine. 2008;4(3):226-236.
96. Nhan TQ, Liles WC, Schwartz SM. Physiological functions of caspases beyond cell death. Am J Pathol. 2006;169(3):729-737.
97. Ghavami S, Hashemi M, Ande SR, et al. Apoptosis and cancer: mutations within caspase genes. J Med Genet. 2009;46(8):497-510.
98. Salvesen GS. Caspases and apoptosis. Essays Biochem. 2002;38:9-19.
99. Xing Y, Xiong W, Zhu L, Osawa E, Hussin S, Dai LM. DNA damage in embryonic stem cells caused by nanodiamonds. ACS Nano. 2011;5(3):2376-2384.
100. Zhu L, Chang DW, Dai LM, Hong YL. DNA damage induced by multiwalled carbon nanotubes in mouse embryonic stem cells. Nano Lett. 2007;7(12):3592-3597.
101. Nicholson DW, Ali A, Thornberry NA, et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature. 1995;376(6535):37-43.
102. Zhang G, Chang HC, Amatore C, Chen Y, Jiang H, Wang XM. Apoptosis induction and inhibition of drug resistant tumor growth in vivo involving daunorubicin-loaded graphene-gold composites. J Mater Chem B. 2013;1(4):493-499.
103. Gotoh Y, Hiraiwa K, Nagayama M. In vitro mineralization of osteoblastic cells derived from human bone. Bone Miner. 1990;8(3):239-250.
104. Strait KA, Dabbas B, Hammond EH, Warnick CT, Iistrup SJ, Ford CD. Cell cycle blockade and differentiation of ovarian cancer cells by the histone deacetylase inhibitor trichostatin a are associated with changes in p21, Rb, and Id proteins. Mol Cancer Ther. 2002;1(13):1181-1190.
105. Kalbacova M, Broz A, Kong J, Kalbac M. Graphene substrates promote adherence of human osteoblasts and mesenchymal stromal cells. Carbon N Y. 2010;48(15):4323-4329.
106. Li M, Wang YB, Liu Q, et al. In situ synthesis and biocompatibility of nano hydroxyapatite on pristine and chitosan functionalized graphene oxide. J Mater Chem B. 2013;1(4):475-484.
107. Liu Y, Huang J, Li H. Synthesis of hydroxyapatite-reduced graphite oxide nanocomposites for biomedical applications: oriented nucleation and epitaxial growth of hydroxyapatite. J Mater Chem B. 2013;1(13):1826-1834.
108. Zhang X, Li M, Wang YB, et al. Cell response of nanographene platelets to human osteoblast-like MG63 cells. J Biomed Mater Res A. 2014;102(3):732-742.